Nilüfer Ertekin-Taner, MD, PHD, FANA
Mayo Clinic, Florida
Dr. Nilüfer Ertekin-Taner is the enterprise chair of the Department of Neuroscience and a professor of neurology and neuroscience at Mayo Clinic in Florida. She is a physician-scientist with seminal contributions to the field of Alzheimer’s disease and related neurodegenerative conditions. Her innovative, groundbreaking work combining complex genomics and deep endophenotypes is essential for the discovery of molecular disease mechanisms, new treatments and biomarkers for these devastating and currently incurable conditions. Dr. Ertekin-Taner is recognized with the distinction of the Roy E. & Merle Meyer Professorship in Neuroscience. Dr. Ertekin-Taner has pioneered the endophenotype approach in genetic studies of Alzheimer’s disease and related disorders (ADRD). Her laboratory applies leading-edge analytic approaches to integrate biological traits with multi-omics data to discover precision medicine therapies and biomarkers in ADRD. Dr. Ertekin-Taner is a principal investigator of AMP-AD and Resilience-AD and was a principal investigator of M2OVE-AD consortia and Florida Consortium for African American AD Studies. She is the contact principal investigator of the CLEAR-AD U19 Program comprising 13 sites and nearly 100 investigators focused on precision medicine biomarker and therapeutic discoveries.